Jiangsu Hengrui | 600276

Stock Price
58.71
Daily Change
-0.19 -0.32%
Monthly
-9.01%
Yearly
31.52%
Q1 Forecast
56.06



Peers Price Chg Day Year Date
Cspc Pharmaceutical 10.15 -0.33 -3.15% 123.57% Feb/12
Sino Biopharmaceutical 6.61 -0.22 -3.22% 115.31% Feb/12
Sh Fosun Pharma 26.90 -0.33 -1.21% 7.60% Feb/12
Zhangzhou Pientzehuang Pharmaceutical 165.74 -1.85 -1.10% -19.72% Feb/12
Kangmei Pharma 1.91 -0.01 -0.52% -17.32% Feb/12
Sh Pharmaceutical 17.20 -0.07 -0.41% -14.17% Feb/12
WuXi AppTec 104.98 2.84 2.78% 84.63% Feb/12

Indexes Price Day Year Date
SHANGHAI 4133 1.30 0.03% 24.03% Feb/12
SHANGHAI 50 3077 -11.74 -0.38% 16.49% Feb/12

Jiangsu Hengrui Me. traded at 58.73 this Thursday February 12th, decreasing 0.17 or 0.29 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui lost 8.02 percent. Over the last 12 months, its price rose by 32.16 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 56.06 by the end of this quarter and at 52.47 in one year, according to Trading Economics global macro models projections and analysts expectations.

Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.